Baidu
map

政策与人文

订阅

MedSci主页 / 所有栏目 / 政策与人文

国务院部署《政府工作报告》重点工作部门分工，国家中医药局负责这些方面

2018-04-17 秦宇龙 中国中医

国务院部署《政府工作报告》重点工作部门分工国家中医药局负责这些方面
关注

近日，国务院发布关于落实《政府工作报告》重点工作部门分工的意见。其中，国家中医药管理局负责工作涉及深入推进供给侧结构性改革、深化基础性关键领域改革、提高保障和改善民生水平等方面。

近日，国务院发布关于落实《政府工作报告》重点工作部门分工的意见。其中，国家中医药管理局负责工作涉及深入推进供给侧结构性改革、深化基础性关键领域改革、提高保障和改善民生水平等方面。

在深入推进供给侧结构性改革，发展壮大新动能方面，国家中医药管理局等部门按职责分工负责做大做强新兴产业集群，实施大数据发展行动，加强新一代人工智能研发应用，在医疗、养老、教育、文化、体育等多领域推进“互联网+”。加快发展现代服务业。发展智能产业，拓展智能生活，建设智慧社会。运用新技术、新业态、新模式，大力改造提升传统产业等。

在深化基础性关键领域改革，推进社会体制改革中，国家中医药管理局等部门按职责分工负责深化公立医院综合改革，协调推进医疗价格、人事薪酬、药品流通、医保支付改革，提高医疗卫生服务质量，下大力气解决群众看病就医难题。深入推进教育、文化、体育等改革，充分释放社会领域巨大发展潜力。

围绕提高保障和改善民生水平，实施健康中国战略，国家中医药管理局等部门按职责分工负责加大医护人员培养力度，加强全科医生、儿科医生队伍建设，推进分级诊疗和家庭医生签约服务。通过发展“互联网+医疗”、医联体等，把优质医疗资源下沉。继续提高基本公共卫生服务经费人均财政补助标准。坚持预防为主，加强重大疾病防控。改善妇幼保健服务。支持中医药事业传承创新发展。鼓励中西医结合。

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1945505, encodeId=ea4d1945505f2, content=<a href='/topic/show?id=f7cb9588e49' target=_blank style='color:#2F92EE;'>#重点工作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95887, encryptionId=f7cb9588e49, topicName=重点工作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Thu Jul 26 12:38:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046493, encodeId=973b20464937f, content=<a href='/topic/show?id=e5d74e881ff' target=_blank style='color:#2F92EE;'>#工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47881, encryptionId=e5d74e881ff, topicName=工作报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Wed Apr 18 09:38:00 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077171, encodeId=d12920e7171c3, content=<a href='/topic/show?id=af892152021' target=_blank style='color:#2F92EE;'>#中医药局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21520, encryptionId=af892152021, topicName=中医药局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Mon Dec 03 23:38:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409485, encodeId=4ed81409485fd, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Apr 19 03:38:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449928, encodeId=b74a14499287e, content=<a href='/topic/show?id=bf3e5e46080' target=_blank style='color:#2F92EE;'>#政府工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57460, encryptionId=bf3e5e46080, topicName=政府工作报告)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b15523194, createdName=minlingfeng, createdTime=Thu Apr 19 03:38:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306673, encodeId=d5383066e38b, content=不错.学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Apr 17 13:23:37 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306664, encodeId=7ed0306664a4, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Tue Apr 17 12:53:39 CST 2018, time=2018-04-17, status=1, ipAttribution=)]
    2018-07-26 sjq027

    #重点工作#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1945505, encodeId=ea4d1945505f2, content=<a href='/topic/show?id=f7cb9588e49' target=_blank style='color:#2F92EE;'>#重点工作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95887, encryptionId=f7cb9588e49, topicName=重点工作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Thu Jul 26 12:38:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046493, encodeId=973b20464937f, content=<a href='/topic/show?id=e5d74e881ff' target=_blank style='color:#2F92EE;'>#工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47881, encryptionId=e5d74e881ff, topicName=工作报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Wed Apr 18 09:38:00 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077171, encodeId=d12920e7171c3, content=<a href='/topic/show?id=af892152021' target=_blank style='color:#2F92EE;'>#中医药局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21520, encryptionId=af892152021, topicName=中医药局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Mon Dec 03 23:38:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409485, encodeId=4ed81409485fd, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Apr 19 03:38:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449928, encodeId=b74a14499287e, content=<a href='/topic/show?id=bf3e5e46080' target=_blank style='color:#2F92EE;'>#政府工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57460, encryptionId=bf3e5e46080, topicName=政府工作报告)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b15523194, createdName=minlingfeng, createdTime=Thu Apr 19 03:38:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306673, encodeId=d5383066e38b, content=不错.学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Apr 17 13:23:37 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306664, encodeId=7ed0306664a4, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Tue Apr 17 12:53:39 CST 2018, time=2018-04-17, status=1, ipAttribution=)]
    2018-04-18 axin009

    #工作报告#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1945505, encodeId=ea4d1945505f2, content=<a href='/topic/show?id=f7cb9588e49' target=_blank style='color:#2F92EE;'>#重点工作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95887, encryptionId=f7cb9588e49, topicName=重点工作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Thu Jul 26 12:38:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046493, encodeId=973b20464937f, content=<a href='/topic/show?id=e5d74e881ff' target=_blank style='color:#2F92EE;'>#工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47881, encryptionId=e5d74e881ff, topicName=工作报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Wed Apr 18 09:38:00 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077171, encodeId=d12920e7171c3, content=<a href='/topic/show?id=af892152021' target=_blank style='color:#2F92EE;'>#中医药局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21520, encryptionId=af892152021, topicName=中医药局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Mon Dec 03 23:38:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409485, encodeId=4ed81409485fd, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Apr 19 03:38:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449928, encodeId=b74a14499287e, content=<a href='/topic/show?id=bf3e5e46080' target=_blank style='color:#2F92EE;'>#政府工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57460, encryptionId=bf3e5e46080, topicName=政府工作报告)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b15523194, createdName=minlingfeng, createdTime=Thu Apr 19 03:38:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306673, encodeId=d5383066e38b, content=不错.学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Apr 17 13:23:37 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306664, encodeId=7ed0306664a4, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Tue Apr 17 12:53:39 CST 2018, time=2018-04-17, status=1, ipAttribution=)]
    2018-12-03 124987c6m36暂无昵称

    #中医药局#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1945505, encodeId=ea4d1945505f2, content=<a href='/topic/show?id=f7cb9588e49' target=_blank style='color:#2F92EE;'>#重点工作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95887, encryptionId=f7cb9588e49, topicName=重点工作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Thu Jul 26 12:38:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046493, encodeId=973b20464937f, content=<a href='/topic/show?id=e5d74e881ff' target=_blank style='color:#2F92EE;'>#工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47881, encryptionId=e5d74e881ff, topicName=工作报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Wed Apr 18 09:38:00 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077171, encodeId=d12920e7171c3, content=<a href='/topic/show?id=af892152021' target=_blank style='color:#2F92EE;'>#中医药局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21520, encryptionId=af892152021, topicName=中医药局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Mon Dec 03 23:38:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409485, encodeId=4ed81409485fd, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Apr 19 03:38:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449928, encodeId=b74a14499287e, content=<a href='/topic/show?id=bf3e5e46080' target=_blank style='color:#2F92EE;'>#政府工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57460, encryptionId=bf3e5e46080, topicName=政府工作报告)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b15523194, createdName=minlingfeng, createdTime=Thu Apr 19 03:38:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306673, encodeId=d5383066e38b, content=不错.学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Apr 17 13:23:37 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306664, encodeId=7ed0306664a4, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Tue Apr 17 12:53:39 CST 2018, time=2018-04-17, status=1, ipAttribution=)]
    2018-04-19 cathymary

    #医药#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1945505, encodeId=ea4d1945505f2, content=<a href='/topic/show?id=f7cb9588e49' target=_blank style='color:#2F92EE;'>#重点工作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95887, encryptionId=f7cb9588e49, topicName=重点工作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Thu Jul 26 12:38:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046493, encodeId=973b20464937f, content=<a href='/topic/show?id=e5d74e881ff' target=_blank style='color:#2F92EE;'>#工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47881, encryptionId=e5d74e881ff, topicName=工作报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Wed Apr 18 09:38:00 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077171, encodeId=d12920e7171c3, content=<a href='/topic/show?id=af892152021' target=_blank style='color:#2F92EE;'>#中医药局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21520, encryptionId=af892152021, topicName=中医药局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Mon Dec 03 23:38:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409485, encodeId=4ed81409485fd, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Apr 19 03:38:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449928, encodeId=b74a14499287e, content=<a href='/topic/show?id=bf3e5e46080' target=_blank style='color:#2F92EE;'>#政府工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57460, encryptionId=bf3e5e46080, topicName=政府工作报告)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b15523194, createdName=minlingfeng, createdTime=Thu Apr 19 03:38:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306673, encodeId=d5383066e38b, content=不错.学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Apr 17 13:23:37 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306664, encodeId=7ed0306664a4, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Tue Apr 17 12:53:39 CST 2018, time=2018-04-17, status=1, ipAttribution=)]
    2018-04-19 minlingfeng

    #政府工作报告#

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1945505, encodeId=ea4d1945505f2, content=<a href='/topic/show?id=f7cb9588e49' target=_blank style='color:#2F92EE;'>#重点工作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95887, encryptionId=f7cb9588e49, topicName=重点工作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Thu Jul 26 12:38:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046493, encodeId=973b20464937f, content=<a href='/topic/show?id=e5d74e881ff' target=_blank style='color:#2F92EE;'>#工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47881, encryptionId=e5d74e881ff, topicName=工作报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Wed Apr 18 09:38:00 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077171, encodeId=d12920e7171c3, content=<a href='/topic/show?id=af892152021' target=_blank style='color:#2F92EE;'>#中医药局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21520, encryptionId=af892152021, topicName=中医药局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Mon Dec 03 23:38:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409485, encodeId=4ed81409485fd, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Apr 19 03:38:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449928, encodeId=b74a14499287e, content=<a href='/topic/show?id=bf3e5e46080' target=_blank style='color:#2F92EE;'>#政府工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57460, encryptionId=bf3e5e46080, topicName=政府工作报告)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b15523194, createdName=minlingfeng, createdTime=Thu Apr 19 03:38:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306673, encodeId=d5383066e38b, content=不错.学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Apr 17 13:23:37 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306664, encodeId=7ed0306664a4, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Tue Apr 17 12:53:39 CST 2018, time=2018-04-17, status=1, ipAttribution=)]
    2018-04-17 虈亣靌

    不错.学习了.谢谢分享

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1945505, encodeId=ea4d1945505f2, content=<a href='/topic/show?id=f7cb9588e49' target=_blank style='color:#2F92EE;'>#重点工作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95887, encryptionId=f7cb9588e49, topicName=重点工作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Thu Jul 26 12:38:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046493, encodeId=973b20464937f, content=<a href='/topic/show?id=e5d74e881ff' target=_blank style='color:#2F92EE;'>#工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47881, encryptionId=e5d74e881ff, topicName=工作报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Wed Apr 18 09:38:00 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077171, encodeId=d12920e7171c3, content=<a href='/topic/show?id=af892152021' target=_blank style='color:#2F92EE;'>#中医药局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21520, encryptionId=af892152021, topicName=中医药局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Mon Dec 03 23:38:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409485, encodeId=4ed81409485fd, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Apr 19 03:38:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449928, encodeId=b74a14499287e, content=<a href='/topic/show?id=bf3e5e46080' target=_blank style='color:#2F92EE;'>#政府工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57460, encryptionId=bf3e5e46080, topicName=政府工作报告)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b15523194, createdName=minlingfeng, createdTime=Thu Apr 19 03:38:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306673, encodeId=d5383066e38b, content=不错.学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Apr 17 13:23:37 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306664, encodeId=7ed0306664a4, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Tue Apr 17 12:53:39 CST 2018, time=2018-04-17, status=1, ipAttribution=)]
    2018-04-17 清风拂面

    谢谢分享学习

    0

Baidu
map
Baidu
map
Baidu
map